Filing Flows › Health Catalyst (HCAT) › Capital expenditures
Health Catalyst (HCAT) capital expenditures by quarter
Health Catalyst's capital expenditures were $345K in Q2 2026 (second quarter 2026), +2% from Q1 2026. Over the last 4 quarters it ranged from $273K (Q4 2025) to $670K (Q1 2025).
| Quarter | Capital expenditures | Q/Q | Y/Y |
|---|---|---|---|
| Q2 2026 | $345K | +2% | — |
| Q1 2026 | $338K | +24% | -50% |
| Q4 2025 | $273K | -59% | — |
| Q1 2025 | $670K | — | — |
Q2 2026 at a glance
Health Catalyst, Q2 2026: revenue $70.5M (-13% year over year), operating margin -51.8%, net loss $40.5M, operating cash flow $275K. The chart follows the revenue to costs, profit and cash.
Questions
What is Health Catalyst's capital expenditures?
Health Catalyst's capital expenditures were $345K in Q2 2026 (second quarter 2026), +2% from Q1 2026.
How has Health Catalyst's capital expenditures changed?
Over the last 4 quarters it ranged from $273K (Q4 2025) to $670K (Q1 2025).